日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Patient-reported outcomes with trastuzumab deruxtecan in hormone receptor-positive, HER2-low or HER2-ultralow metastatic breast cancer: results from the randomized DESTINY-Breast06 trial

曲妥珠单抗德鲁替康治疗激素受体阳性、HER2低表达或HER2超低表达转移性乳腺癌的患者报告结局：来自随机DESTINY-Breast06试验的结果

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105082
Hu, X; Curigliano, G; Yonemori, K; Bardia, A; Barrios, C H; Sohn, J; Lévy, C; Jacot, W; Tsurutani, J; Roborel de Climens, A; Wu, X; Andrzejuk-Ćwik, A; Mbanya, Z; Dent, R
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Development and Content Validation of the Patient's Qualitative Assessment of Treatment - Real-World (PQAT-RW): An Instrument to Evaluate Benefits and Disadvantages of Treatments in Real-World Settings

患者治疗定性评估量表（真实世界版）（PQAT-RW）的开发和内容验证：一种评估真实世界治疗益处和弊端的工具

期刊:Patient-Related Outcome Measures
影响因子:1.8
doi:10.2147/PROM.S468623
Roborel de Climens, Aude; Findley, Amy; Bury, Denise P; Brady, Keri J S; Reaney, Matthew; Gater, Adam
发表日期：2024
文献求助 收藏

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers

来自 LixiLan ONE CAN 胰岛素笔子研究的 iGlarLixi SoloStar 胰岛素笔易用性：2 型糖尿病患者及其医疗保健提供者的问卷调查结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01353-6
Yale, Jean-François; Roborel de Climens, Aude; Aggarwal, Naresh; Dex, Terry; Gerstein, Hertzel C; Harris, Stewart; Hramiak, Irene; Stewart, John; Leiter, Lawrence A
代谢
糖尿病
免疫/内分泌
发表日期：2023
文献求助 收藏

Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC

对因非小细胞肺癌危及生命并发症住院的患者进行帕博利珠单抗挽救性免疫治疗

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2021.100147
Roborel de Climens, Ferréol; Chouaid, Christos; Poulet, Claire; Leroy, Vincent; Stoven, Luc; Cortot, Alexis Benjamin; Dhalluin, Xavier; Gauvain, Clément
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK

了解2型糖尿病患者停止治疗的原因、态度和教育需求：来自美国和英国在线患者调查的结果

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-020-00843-9
Roborel de Climens, Aude; Pain, Emilie; Boss, Anders; Shaunik, Alka
糖尿病
代谢
发表日期：2020
文献求助 收藏

Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

掌控血糖：一项随机试验，评估在血糖控制不佳的 2 型糖尿病患者中，自行调整胰岛素甘精 300 U/mL 剂量与医生管理剂量调整的疗效和安全性。

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.13697
Russell-Jones, David; Dauchy, Arnaud; Delgado, Elías; Dimitriadis, George; Frandsen, Hans A; Popescu, Luiza; Schultes, Bernd; Strojek, Krzysztof; Bonnemaire, Mireille; Roborel de Climens, Aude; Davies, Melanie
代谢
糖尿病
免疫/内分泌
发表日期：2019
文献求助 收藏

A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes

静息、激活、HTLV-1 转化和 Tax 表达的人类 T 淋巴细胞中端粒酶与端粒 DNA 结合蛋白 TRF1、TRF2 和 Pot1 之间的平衡转录

期刊:Retrovirology
影响因子:2.7
doi:10.1186/1742-4690-2-77
Emmanuelle Escoffier, Amélie Rezza, Aude Roborel de Climens, Aurélie Belleville, Louis Gazzolo, Eric Gilson, Madeleine Duc Dodon
免疫
细胞生物学
其它细胞
发表日期：2005
文献求助 收藏

The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase

p53诱导的TSAP6基因产物调控细胞凋亡和细胞周期，并与Nix和Myt1激酶相互作用。

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.0530298100
Passer, Brent J; Nancy-Portebois, Vanessa; Amzallag, Nathalie; Prieur, Sylvie; Cans, Christophe; Roborel de Climens, Aude; Fiucci, Giusy; Bouvard, Veronique; Tuynder, Marcel; Susini, Laurent; Morchoisne, Stéphanie; Crible, Virginie; Lespagnol, Alexandra; Dausset, Jean; Oren, Moshe; Amson, Robert; Telerman, Adam
信号转导
细胞生物学
凋亡
表观遗传
发表日期：2003
文献求助 收藏